LifeScience
Agilent Reports Third-Quarter Fiscal Year 2022 Financial Results
Highlights: Revenue of $1.72 billion represents 8% reported growth year-over-year; and up 13% on a core(1) basis. GAAP net income of $329 million ...
August 17, 2022 | News
Jackson ImmunoResearch announces new range of antibodies for serology and diagnostics market
Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new addition to its range of pro...
August 10, 2022 | News
Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapies...
August 09, 2022 | News
Biosynth Carbosynth to offer Enzyme Development following Acquisition of EUCODIS Bioscience
Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces today that it has signed an agreemen...
August 08, 2022 | News
Thermo Fisher's $76 million investment expands cell culture media production
To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, Thermo Fisher Scientific has expanded its ...
August 04, 2022 | News
Bio-Rad Acquires Curiosity Diagnostics
Curiosity Diagnostics, a late-stage, pre-commercial platform company, is in the process of developing a sample-to-answer, rapid diagnostics PCR system for ...
August 04, 2022 | News
Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis
PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solution...
August 03, 2022 | News
Eppendorf opens new site in Singapore
New subsidiary at the center of the Asian life science growth markets Targeted strengthening of customer focus with high-tech laboratory for pipette cal...
August 01, 2022 | News
Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney
The consortium partnership strives to advance a new vaccine concept that confers highly cross-reactive protection against numerous SARS-CoV-2 variants...
July 27, 2022 | News
Sustainable Manufacturing Practices: The Key to Mitigating Antimicrobial Resistance
The workshop program included training on the importance of sustainability in manufacturing practices of antibiotics, as well as a presentation of th...
July 27, 2022 | News
Triastek & Lilly to explore the application of 3D printing technology in oral delivery of drugs
According to the agreement, the project will focus on the targeted release of drugs in the intestine. Triastek will focus on two aspects: Firstly, conduct ...
July 14, 2022 | News
Discovery Life Sciences acquires AllCells
Discovery Life Sciences™ (Discovery), the biospecimens and biomarkers™ specialists, today announced the acquisition of AllCells, a l...
July 13, 2022 | News
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...
July 12, 2022 | News
Eppendorf Award for Young European Investigators 2022 goes to Thi Hoang Duong Nguyen; United Kingdom
Thi Hoang Duong Nguyen, born in 1987, receives the 20,000 euro award for her pioneering work on the structure and function of two RNA-protein complexes tha...
July 08, 2022 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
